\-\ Texto\\:\\ \ \(0\)\
\-\ well\\ nourished\\ and\\ well\\ developed\\ male\\.\ \(0\)\
\-\ high\\ signal\\ involving\\ the\\ pachymeninges\\ diffusely\\ in\\ a\\ smooth\\ pattern\\ without\\ enhancement\\ of\\ the\\ leptomeninges\\ or\\ loss\\ of\\ the\\ grey\\-white\\ matter\\ differentiation\\.\\ there\\ is\\ diffuse\\ enhancement\\ with\\ contrast\\ administration\\ \\-\\ without\\ an\\ abnormal\\ focus\\,\\ nodularity\\,\\ or\\ rim\\ enhancing\\ lesion\\.\ \(0\)\
\-\ intracranial\\ hypotension\ \(1\)\
\-\ intracranial\\ hypotension\ \(1\)\
\-\ meningitis\\ \\(pachymeningitis\\)\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ post\\ surgical\\ changes\\ with\\ dural\\ thickening\ \(0\)\
\-\ 40\\ yo\\ man\\ presents\\ with\\ a\\ three\\ week\\ history\\ of\\ headaches\\ that\\ exacerbate\\ with\\ position\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hypotension\\:\\ 0\\.12918517248173797\ \(0\)\
\-\ exacerbate\\:\\ 0\\.10027618819020435\ \(0\)\
\-\ pachymeninges\\:\\ 0\\.09527044611479492\ \(0\)\
\-\ pachymeningitis\\:\\ 0\\.09527044611479492\ \(0\)\
\-\ intracranial\\:\\ 0\\.08917312930591859\ \(0\)\
\-\ grey\\-white\\:\\ 0\\.08480997870260722\ \(0\)\
\-\ leptomeninges\\:\\ 0\\.08316144299119335\ \(0\)\
\-\ nodularity\\:\\ 0\\.06643865703063397\ \(0\)\
\-\ nourished\\:\\ 0\\.06360440466465249\ \(0\)\
\-\ enhancement\\:\\ 0\\.05655527817587743\ \(0\)\
\-\ differentiation\\:\\ 0\\.05620788329537262\ \(0\)\
\-\ meningitis\\:\\ 0\\.05473446653447674\ \(0\)\
\-\ diffusely\\:\\ 0\\.05328035498316337\ \(0\)\
\-\ dural\\:\\ 0\\.05114431591980977\ \(0\)\
\-\ without\\:\\ 0\\.049679337440942224\ \(0\)\
\-\ well\\:\\ 0\\.047730393900460515\ \(0\)\
\-\ focus\\:\\ 0\\.047392403475875595\ \(0\)\
\-\ smooth\\:\\ 0\\.04617709393497125\ \(0\)\
\-\ rim\\:\\ 0\\.04465458509507003\ \(0\)\
\-\ 40\\:\\ 0\\.044384723443063864\ \(0\)\
\-\ position\\:\\ 0\\.04392621051776193\ \(0\)\
\-\ administration\\:\\ 0\\.04379827487534778\ \(0\)\
\-\ matter\\:\\ 0\\.041536789758034535\ \(0\)\
\-\ developed\\:\\ 0\\.04061809240536684\ \(0\)\
\-\ pattern\\:\\ 0\\.040326448630509604\ \(0\)\
\-\ headaches\\:\\ 0\\.040326448630509604\ \(0\)\
\-\ involving\\:\\ 0\\.03701737362967029\ \(0\)\
\-\ week\\:\\ 0\\.03582735084355837\ \(0\)\
\-\ thickening\\:\\ 0\\.035760797156708046\ \(0\)\
\-\ three\\:\\ 0\\.035563262078356916\ \(0\)\
\-\ post\\:\\ 0\\.03322018559348511\ \(0\)\
\-\ enhancing\\:\\ 0\\.033085846084997025\ \(0\)\
\-\ diffuse\\:\\ 0\\.03193836321451006\ \(0\)\
\-\ yo\\:\\ 0\\.031745080534601997\ \(0\)\
\-\ loss\\:\\ 0\\.030623014474919004\ \(0\)\
\-\ changes\\:\\ 0\\.030235160200432844\ \(0\)\
\-\ abnormal\\:\\ 0\\.03008755852240631\ \(0\)\
\-\ high\\:\\ 0\\.028870939025639697\ \(0\)\
\-\ signal\\:\\ 0\\.02781573247250344\ \(0\)\
\-\ metastatic\\:\\ 0\\.026556906217482596\ \(0\)\
\-\ man\\:\\ 0\\.024949775840617274\ \(0\)\
\-\ or\\:\\ 0\\.024728956764535986\ \(0\)\
\-\ contrast\\:\\ 0\\.023614514651949445\ \(0\)\
\-\ \\-\\:\\ 0\\.02261393158899214\ \(0\)\
\-\ surgical\\:\\ 0\\.022175577410511772\ \(0\)\
\-\ presents\\:\\ 0\\.021551164142073156\ \(0\)\
\-\ lesion\\:\\ 0\\.0214883361234624\ \(0\)\
\-\ male\\:\\ 0\\.01907661157885769\ \(0\)\
\-\ that\\:\\ 0\\.018221984303195347\ \(0\)\
\-\ disease\\:\\ 0\\.017243673348342026\ \(0\)\
\-\ there\\:\\ 0\\.015700192055123317\ \(0\)\
\-\ an\\:\\ 0\\.014588455114626293\ \(0\)\
\-\ history\\:\\ 0\\.014570549848235597\ \(0\)\
\-\ a\\:\\ 0\\.009792587699224722\ \(0\)\
\-\ \\(\\:\\ 0\\.008918046003010624\ \(0\)\
\-\ \\)\\:\\ 0\\.008809107310040804\ \(0\)\
\-\ is\\:\\ 0\\.0069418614615398225\ \(0\)\
\-\ \\,\\:\\ 0\\.006684199148574997\ \(0\)\
\-\ with\\:\\ 0\\.005777984004438999\ \(0\)\
\-\ in\\:\\ 0\\.005202434940003147\ \(0\)\
\-\ the\\:\\ 0\\.005120343877912066\ \(0\)\
\-\ of\\:\\ 0\\.004314955585110683\ \(0\)\
\-\ and\\:\\ 0\\.0022223334041014623\ \(0\)\
\-\ \\.\\:\\ 0\\.0013147976332350472\ \(0\)\
